Methods of using and compositions comprising N-desmethylzolpidem
AssigneeSepracor Inc.
InventorThomas P. Jerussi
Life of this patent
Estimating the term…
Abstract
The invention is directed to compositions comprising, and methods of using, N-desmethylzolpidem in the treatment and prevention of diseases and conditions in mammals. Examples of such diseases and conditions include, but are not limited to: sleep disorders such as insomnia; affective disorders such as depression, attention deficit disorder, and attention deficit disorder with hyperactivity or attention deficit/hyperactivity disorder; convulsive disorders such as epilepsy; anxiety; aggressive behavior; spasticity or acute muscle spasm; behavioral disorders; schizophrenia; and disorders associated with abnormal plasma hormone levels such as endocrine disorders.
Claims31
A method of treating or preventing a disease or condition in a patient which is affected by the modulation of one or more central or peripheral benzodiazepine receptors, which comprises administering to a patient in need of such treatment or prevention a therapeutically effective amount of N-desmethylzolpidem, or a pharmaceutically acceptable salt, solvate, or clathrate thereof.
A pharmaceutical composition comprising N-desmethylzolpidem, or a pharmaceutically acceptable salt, solvate, or clathrate thereof.
An individual dosage form of N-desmethylzolpidem which comprises N-desmethylzolpidem, or a pharmaceutically acceptable salt, solvate, or clathrate thereof.
Dependencies are inferred from the claim text.